BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22498943)

  • 1. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
    Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K
    Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
    Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
    Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
    Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics.
    Yamamoto S; Tsuda H; Yoshikawa T; Kudoh K; Kita T; Furuya K; Tamai S; Matsubara O
    Am J Surg Pathol; 2007 Jul; 31(7):999-1006. PubMed ID: 17592265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
    Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
    J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway.
    Miyazawa M; Yasuda M; Fujita M; Hirabayashi K; Hirasawa T; Kajiwara H; Muramatsu T; Miyazaki S; Harasawa M; Matsui N; Ogane N; Murakami M; Mikami M; Yanase T; Osamura RY
    J Obstet Gynaecol Res; 2010 Apr; 36(2):448-53. PubMed ID: 20492406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas.
    Yamamoto S; Tsuda H; Honda K; Takano M; Tamai S; Imoto I; Inazawa J; Yamada T; Matsubara O
    Histopathology; 2012 Jun; 60(7):1073-83. PubMed ID: 22348389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
    Zhou YL; Deng CS
    Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
    Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
    Histopathology; 2010 May; 56(6):740-9. PubMed ID: 20546339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.
    Koo JS; Jung W
    Pathobiology; 2010; 77(6):289-300. PubMed ID: 21266827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
    Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
    Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.
    Yamamoto S; Tsuda H; Takano M; Kita T; Kudoh K; Furuya K; Tamai S; Matsubara O
    Mod Pathol; 2008 Feb; 21(2):115-24. PubMed ID: 18084257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
    Naruse T; Kawasaki G; Yanamoto S; Mizuno A; Umeda M
    Anticancer Res; 2011 Dec; 31(12):4429-37. PubMed ID: 22199311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial.
    Hirasawa T; Miyazawa M; Yasuda M; Shida M; Ikeda M; Kajiwara H; Matsui N; Fujita M; Muramatsu T; Mikami M
    Int J Gynecol Cancer; 2013 Sep; 23(7):1210-8. PubMed ID: 23899586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
    Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
    Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
    Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible Factor-1α and mTOR as a Potential Therapeutic Target in Endometriosis: An Immunohistochemical Study.
    Badary DM; Abou-Taleb HA; Ibrahim M
    Appl Immunohistochem Mol Morphol; 2023 Oct; 31(9):629-634. PubMed ID: 37668418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway.
    Argyriou P; Papageorgiou SG; Panteleon V; Psyrri A; Bakou V; Pappa V; Spathis A; Economopoulou P; Papageorgiou E; Economopoulos T; Rontogianni D
    Ann Hematol; 2011 Mar; 90(3):315-22. PubMed ID: 20838824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1alpha.
    Wu MH; Chen KF; Lin SC; Lgu CW; Tsai SJ
    Am J Pathol; 2007 Feb; 170(2):590-8. PubMed ID: 17255327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.